XTEN conjugate compositions and methods of making same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10953073
APP PUB NO 20190083577A1
SERIAL NO

16133444

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to extended recombinant polypeptide (XTEN) compositions, conjugate compositions comprising XTEN and XTEN linked to cross-linkers useful for conjugation to pharmacologically active payloads, methods of making highly purified XTEN, methods of making XTEN-linker and XTEN-payload conjugates, and methods of using the XTEN-cross-linker and XTEN-payload compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMUNIX PHARMACEUTICALS INC2 TOWER PL #1100 SOUTH SAN FRANCISCO CA 94080

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ding, Sheng Foster City, US 111 927
Gu, Chen Fremont, US 14 34
McLaughlin, Bryant Millbrae, US 4 31
Podust, Vladimir Castro Valley, US 14 55
Schellenberger, Volker Palo Alto, US 137 3339
Sim, Bee-Cheng Mountain View, US 31 690
Wang, Chia-Wei Santa Clara, US 156 2513

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 23, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 23, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00